Stay updated on Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision tag on the page was updated from v3.5.4 to v3.5.5, indicating a new software release for the site.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision entry was updated from v3.5.3 to v3.5.4, replacing the previous revision tag. This reflects a minor update to the page's revision history rather than changes to core content.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a website release/version change rather than a change to the displayed clinical trial information.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.5.2 replaces the previous Revision: v3.5.0 on the page.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No study data, eligibility criteria, or outcomes were altered.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.